Eagle Pharmaceuticals Ownership | Who Owns Eagle Pharmaceuticals?

Eagle Pharmaceuticals Ownership Summary

Eagle Pharmaceuticals is owned by 64.81% institutional investors, 12.02% insiders, and 23.16% retail investors. Aigh capital management is the largest institutional shareholder, holding 9.25% of EGRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.84% of its assets in Eagle Pharmaceuticals shares.

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Aigh capital management	1.21M	9.25%	$6.78M
Citigroup	1.00M	7.65%	$5.61M
Nantahala capital management	1.00M	7.64%	$5.60M
Aqr capital management	696.80K	5.32%	$3.90M
Vanguard group	564.40K	4.31%	$3.16M
Blackrock	352.76K	2.69%	$1.98M
Bank of america corp /de/	325.52K	2.49%	$1.82M
Morgan stanley	300.45K	2.30%	$1.68M
Renaissance	244.25K	1.87%	$1.37M
Two sigma advisers, lp	224.82K	1.72%	$1.26M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Aigh capital management	1.21M	2.11%	$6.78M
Nantahala capital management	1.00M	0.33%	$5.60M
Ajovista	11.23K	0.18%	$62.90K
Tang capital management	118.86K	0.07%	$665.60K
Rbf capital	128.09K	0.04%	$717.29K
J. goldman & co lp	191.11K	0.03%	$1.07M
Wealthcollab	4.38K	0.02%	$24.50K
Pdt partners	30.01K	0.02%	$168.06K
Point72 asia (singapore) pte.	11.61K	0.01%	$65.03K
Xtx topco	20.20K	0.01%	$113.14K

Top Buyers

Holder	Shares	% Assets	Change
Nantahala capital management	1.00M	0.33%	1.00M
Citigroup	1.00M	0.00%	998.84K
Rbf capital	128.09K	0.04%	128.09K
Cubist systematic strategies	25.81K	0.00%	25.81K
Aigh capital management	1.21M	2.11%	25.00K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock	352.76K	-	-545.04K
Lsv asset management	-	-	-295.39K
Aqr capital management	696.80K	0.01%	-182.28K
State street	35.82K	-	-177.85K
Perceptive advisors	-	-	-173.37K

New Positions

Holder	Shares	% Assets	Change	Value
Nantahala capital management	1.00M	0.33%	1.00M	$5.60M
Rbf capital	128.09K	0.04%	128.09K	$717.29K
Vanguard personalized indexing management	13.63K	0.00%	13.63K	$76.32K
Mackenzie financial	10.79K	0.00%	10.79K	$60.40K
Macquarie group	518.00	-	518.00	$2.90K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-2.00
New york state common retirement fund	-90.00
Nordwand advisors	-100.00
Barrett & company	-100.00
Fortitude family office	-117.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	67	-11.84%	8,484,605	-14.04%	64	1.14%	21	-12.50%	27	-35.71%
Jun 30, 2024	76	-18.28%	9,870,425	-5.60%	75	1.18%	24	-41.46%	42	16.67%
Mar 31, 2024	93	-12.26%	10,455,770	4.33%	79	1.36%	41	-36.92%	36	50.00%
Dec 31, 2023	106	-2.75%	10,021,957	-3.36%	76	1.22%	65	38.30%	24	-48.94%
Sep 30, 2023	109	-13.49%	10,370,529	-3.75%	79	1.16%	47	-16.07%	47	-7.84%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	367.77K	2.84%	-
Vanguard Institutional Extnd Mkt Idx Tr	150.92K	1.16%	-
Fidelity Small Cap Index	107.48K	0.83%	5.54K
AQR Small Cap Multi-Style I	96.26K	0.74%	9.72K
Invesco FTSE RAFI US 1500 Small-Mid ETF	82.42K	0.64%	-39.00
Fidelity Extended Market Index	60.61K	0.47%	3.30K
Schwab US Small-Cap ETF™	50.79K	0.39%	-
Xtrackers Stoxx Global Div100 Swp ETF 1D	48.80K	0.38%	48.80K
Vanguard Health Care ETF	39.89K	0.31%	-39.00
RBC Microcap Value I	36.90K	0.28%	9.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 02, 2023	Tarriff Scott	CEO	Sell	$148.33K
Nov 01, 2023	Tarriff Scott	CEO	Sell	$150.98K
Oct 03, 2023	Tarriff Scott	CEO	Sell	$144.45K
Oct 03, 2023	Tarriff Scott	CEO	Sell	$10.73K
Oct 02, 2023	Tarriff Scott	CEO	Sell	$144.85K

Insider Transactions Trends

Date	Buy	Sell
2024 Q1	-	-
2023 Q4	-	5
2023 Q2	-	6
2023 Q1	-	-
2022 Q4	-	-

EGRX Ownership FAQ

Who owns the most shares of Eagle Pharmaceuticals?

Eagle Pharmaceuticals’s largest shareholders are Aigh capital management (1.21M shares, 9.25%), Citigroup (1M shares, 7.65%), and Nantahala capital management (1M shares, 7.64%). Together, they hold 24.54% of Eagle Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eagle Pharmaceuticals?

Yes, BlackRock owns 2.69% of Eagle Pharmaceuticals, totaling 352.76K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.98M$. In the last quarter, BlackRock decreased its holdings by -545K shares, a -60.71% change.

Who is Eagle Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Aigh capital management is Eagle Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.11% of its assets in 1.21M Eagle Pharmaceuticals shares, valued at 6.78M$.

Who is the top mutual fund holder of Eagle Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eagle Pharmaceuticals shares, with 2.84% of its total shares outstanding invested in 367.77K Eagle Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools